. Linj, 0650 78 67 29 59 DEAD-like helicases superfamily, ATP-dependent helicase (P-loop), SWAP domain LinJ

. Linj, 0880 193 181 3 14 CCR4-Not complex component, Not1, Cell division control protein, negative regulator of transcription, Domain of unknown function (DUF3819) LinJ

. Linj, 1830 45 40 10 17 No domain LinJ

. Linj, 0760 8 - 9 - T-complex protein 10 C-terminus ; Iron/manganese superoxide dismutases, (SODs)

. Linj, Chromosome segregation ATPase, RecF/RecN/SMC N terminal domain LinJ.35.1820 41 36 47 55 Rossmann fold nucleotide-binding protein LinJ.35 10 - U3 small nucleolar RNA-associated protein 6, contains HAT (Half-A-TPR) repeat LinJ, pp.26-43, 1980.

. Linj, 4620 71 78 10 16 ET domains are protein lysine methyltransferase enzymes, Catalytic domain of the Serine/Threonine Kinase, Classical Protein Kinase C alpha; STKs LinJ.35.4780 44 38 - 12 Molecular chaperone DnaK (HSP70), Nucleotide-binding domain of human HYOU1 and similar proteins, heat shock 70 kDa precursor protein, chaperone protein DnaK LinJ, pp.25-26

. Linj, 0070 - - - 3 SAP domain; The SAP (after SAF-A/B, Acinus and PIAS) motif is a putative DNA/RNA binding, Putative DNA-binding (bihelical) motif LinJ, 15804021.

. Crotonase, Enoyl-Coenzyme A hydratase superfamily, Enoyl-CoA hydratase/carnithine racemase LinJ

. Linj, 5530 - - 3 - Catalytic domain of the Serine/Threonine kinase, Proviral Integration Moloney virus (PIM), Forkhead N-terminal region

I. Shikimate-kinase and . Aaa-domain, Adenylate kinase (ADK), bifunctional pantoate ligase/cytidylate kinase, DUF392 LinJ, p.6500

G. Bibliographie-allocco, J. J. Donald, R. Zhong, T. Lee, A. Tang et al., Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro, International Journal for Parasitology, vol.36, issue.12, pp.1249-1259, 2006.
DOI : 10.1016/j.ijpara.2006.06.013

J. -alvar, I. D. Velez, C. Bern, M. Herrero, P. Desjeux et al., Leishmaniasis Worldwide and Global Estimates of Its Incidence, PLoS ONE, vol.83, issue.30, p.35671, 2012.
DOI : 10.1371/journal.pone.0035671.s101

J. C. -antoine, E. Prina, T. Lang, C. , and N. , The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages, Trends in Microbiology, vol.6, issue.10, pp.392-401, 1998.
DOI : 10.1016/S0966-842X(98)01324-9

N. -aulner, A. Danckaert, E. Rouault-hardoin, J. Desrivot, O. Helynck et al., High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery, PLoS Neglected Tropical Diseases, vol.26, issue.4, 2013.
DOI : 10.1371/journal.pntd.0002154.s010

M. -bantscheff, D. Eberhard, Y. Abraham, S. Bastuck, M. Boesche et al., Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors, Nature Biotechnology, vol.392, issue.9, pp.1035-1044, 2007.
DOI : 10.1038/nbt1328

M. -bantscheff, C. Hopf, U. Kruse, and G. Drewes, Proteomics-Based Strategies in Kinase Drug Discovery, Ernst Schering Found Symp Proc, pp.1-28, 2007.
DOI : 10.1007/2789_2007_060

E. -barak, S. Amin-spector, E. Gerliak, S. Goyard, N. Holland et al., Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response, Molecular and Biochemical Parasitology, vol.141, issue.1, pp.99-108, 2005.
DOI : 10.1016/j.molbiopara.2005.02.004

S. -besteiro, R. A. Williams, G. H. Coombs, and J. C. Mottram, Protein turnover and differentiation in Leishmania, International Journal for Parasitology, vol.37, issue.10, pp.1063-1075, 2007.
DOI : 10.1016/j.ijpara.2007.03.008

C. -britto, C. Ravel, P. Bastien, C. Blaineau, M. Pages et al., Conserved linkage groups associated with large-scale chromosomal rearrangements between Old World and New World Leishmania genomes, Gene, vol.222, issue.1, pp.107-117, 1998.
DOI : 10.1016/S0378-1119(98)00472-7

F. -chappuis, S. Sundar, A. Hailu, H. Ghalib, S. Rijal et al., Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?, Nature Reviews Microbiology, vol.14, issue.11, pp.7-16, 2007.
DOI : 10.1038/nrmicro1748

C. E. -clayton, NEW EMBO MEMBER'S REVIEW Life without transcriptional control? From fly to man and back again, The EMBO Journal, vol.21, issue.8, pp.1881-1888, 2002.
DOI : 10.1093/emboj/21.8.1881

S. L. -croft and G. H. Coombs, Leishmaniasis??? current chemotherapy and recent advances in the search for novel drugs, Trends in Parasitology, vol.19, issue.11, pp.502-508, 2003.
DOI : 10.1016/j.pt.2003.09.008

R. -docampo, W. De-souza, K. Miranda, P. Rohloff, and S. N. Moreno, Acidocalcisomes ? conserved from bacteria to man, Nature Reviews Microbiology, vol.72, issue.3, pp.251-261, 2005.
DOI : 10.1038/nrmicro1097

J. -drummelsmith, V. Brochu, I. Girard, N. Messier, and M. Ouellette, Proteome Mapping of the Protozoan Parasite Leishmania and Application to the Study of Drug Targets and Resistance Mechanisms, Molecular & Cellular Proteomics, vol.2, issue.3, pp.146-155, 2003.
DOI : 10.1074/mcp.M200085-MCP200

E. -dülsner, J. J. Fischer, C. Jurinke, and H. Köster, Functional isolation of staurosporine binding protein kinases using CCMS technology, 2009.

E. -durieu, E. Prina, O. Leclercq, N. Oumata, N. Gaboriaud-kolar et al., From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity, Antimicrobial Agents and Chemotherapy, vol.60, issue.5, pp.2822-2833, 2016.
DOI : 10.1128/AAC.00021-16

R. -eglen, R. , and T. , Drug discovery and the human kinome: Recent trends, Pharmacology & Therapeutics, vol.130, issue.2, pp.144-156, 2011.
DOI : 10.1016/j.pharmthera.2011.01.007

Y. Bibliographie-el-fakhry, M. Ouellette, and B. Papadopoulou, A proteomic approach to identify developmentally regulated proteins in Leishmania infantum, PROTEOMICS, vol.2, issue.8, pp.1007-1017, 2002.
DOI : 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G

M. -fiebig, S. Kelly, and E. Gluenz, Comparative Life Cycle Transcriptomics Revises Leishmania mexicana Genome Annotation and Links a Chromosome Duplication with Parasitism of Vertebrates, PLOS Pathogens, vol.16, issue.Pt 1, 2015.
DOI : 10.1371/journal.ppat.1005186.s026

J. J. -fischer, C. Dalhoff, A. K. Schrey, O. Y. Graebner-neé-baessler, S. Michaelis et al., Dasatinib, imatinib and staurosporine capture compounds ??? Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS), Dasatinib, imatinib and staurosporine capture compounds ? Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS), pp.160-168, 2011.
DOI : 10.1016/j.jprot.2011.05.035

A. L. -foucher, N. Rachidi, S. Gharbi, T. Blisnick, P. Bastin et al., Apoptotic Marker Expression in the Absence of Cell Death in Staurosporine-Treated Leishmania donovani, Antimicrobial Agents and Chemotherapy, vol.57, issue.3, pp.1252-1261, 2012.
DOI : 10.1128/AAC.01983-12

S. -goyard, H. Segawa, J. Gordon, M. Showalter, R. Duncan et al., An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans, Molecular and Biochemical Parasitology, vol.130, issue.1, pp.31-42, 2003.
DOI : 10.1016/S0166-6851(03)00142-7

T. A. -haystead, The Purinome, a Complex Mix of Drug and Toxicity Targets, Current Topics in Medicinal Chemistry, vol.6, issue.11, pp.1117-1127, 2006.
DOI : 10.2174/156802606777812059

J. -ito, J. L. Heazlewood, and A. H. Millar, Analysis of the Soluble ATP-Binding Proteome of Plant Mitochondria Identifies New Proteins and Nucleotide Triphosphate Interactions within the Matrix, Journal of Proteome Research, vol.5, issue.12, pp.3459-3469, 2006.
DOI : 10.1021/pr060403j

A. C. -ivens, C. S. Peacock, E. A. Worthey, L. Murphy, G. Aggarwal et al., The Genome of the Kinetoplastid Parasite, Leishmania major, Science, vol.309, issue.5733, pp.436-442, 2005.
DOI : 10.1126/science.1112680

S. -kamhawi, The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections, Microbes and Infection, vol.2, issue.14, pp.1765-1773, 2000.
DOI : 10.1016/S1286-4579(00)01331-9

M. W. -karaman, S. Herrgard, D. K. Treiber, P. Gallant, C. E. Atteridge et al., A quantitative analysis of kinase inhibitor selectivity, Nature Biotechnology, vol.50, issue.1, pp.127-132, 2008.
DOI : 10.1038/nbt1358

P. -kaye and P. Scott, Leishmaniasis: complexity at the host???pathogen interface, Nature Reviews Microbiology, vol.74, issue.8, pp.604-615, 2011.
DOI : 10.1038/nrmicro2608

-. , L. A. Mezulis, S. Yates, C. M. Wass, M. N. Sternberg et al., The Phyre2 web portal for protein modeling, prediction and analysis, Nat Protoc, vol.10, pp.845-858, 2015.

T. -kruger and M. Engstler, Flagellar motility in eukaryotic human parasites, Seminars in Cell & Developmental Biology, vol.46, pp.113-127, 2015.
DOI : 10.1016/j.semcdb.2015.10.034

M. C. -laffitte, P. Leprohon, D. Legare, and M. Ouellette, Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance, Parasitology Research, vol.4, issue.10, pp.3699-3703, 2016.
DOI : 10.1016/j.ijpddr.2013.11.002

O. -leclercq, K. Bartho, E. Duelsner, L. Von-kleist, P. F. Gherardini et al., Enrichment of Leishmania donovani ATP-binding proteins using a staurosporine capture compound, Journal of Proteomics, vol.86, pp.97-104, 2013.
DOI : 10.1016/j.jprot.2013.05.002

J. -lee and M. Bogyo, Target deconvolution techniques in modern phenotypic profiling, Current Opinion in Chemical Biology, vol.17, issue.1, pp.118-126, 2013.
DOI : 10.1016/j.cbpa.2012.12.022

E. -lindgren, Y. Andersson, J. E. Suk, B. Sudre, and J. C. Semenza, Monitoring EU Emerging Infectious Disease Risk Due to Climate Change, Science, vol.336, issue.6080, 2012.
DOI : 10.1126/science.1215735

V. M. -longshaw, J. P. Chapple, M. S. Balda, M. E. Cheetham, and G. L. Blatch, Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases, Journal of Cell Science, vol.117, issue.5, pp.701-710, 2004.
DOI : 10.1242/jcs.00905

M. -maroli, M. D. Feliciangeli, L. Bichaud, R. N. Charrel, and L. Gradoni, Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern, Medical and Veterinary Entomology, vol.91, issue.Suppl. 10, pp.123-147, 2013.
DOI : 10.1111/j.1365-2915.2012.01034.x

L. -meijer, A. Skaltsounis, P. Magiatis, P. Polychronopoulos, M. Knockaert et al., GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins, Chemistry & Biology, vol.10, issue.12, pp.1255-1266, 2003.
DOI : 10.1016/j.chembiol.2003.11.010

M. A. -morales, O. Renaud, W. Faigle, S. L. Shorte, and G. F. Späth, Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity, International Journal for Parasitology, vol.37, issue.11, pp.1187-1199, 2007.
DOI : 10.1016/j.ijpara.2007.03.006

M. A. -morales, R. Watanabe, M. Dacher, P. Chafey, J. Osorio-y-fortea et al., Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage, Proceedings of the National Academy of Sciences, vol.107, issue.18, pp.8381-8386, 2010.
DOI : 10.1073/pnas.0914768107

M. A. -morales, R. Watanabe, C. Laurent, P. Lenormand, J. C. Rousselle et al., Phosphoproteomic analysis ofLeishmania donovani pro- and amastigote stages, PROTEOMICS, vol.38, issue.2, pp.350-363, 2008.
DOI : 10.1002/pmic.200700697

-. , H. W. Berman, J. D. Davies, C. R. Saravia, and N. G. , Advances in leishmaniasis, The Lancet, vol.366, pp.1561-1577, 2005.

J. M. -murray and D. E. Bussiere, Targeting the Purinome, Chemogenomics, Methods in Molecular Biology, vol.575, pp.47-92, 2009.
DOI : 10.1007/978-1-60761-274-2_3

C. -naula, M. Parsons, and J. C. Mottram, Protein kinases as drug targets in trypanosomes and Leishmania, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1754, issue.1-2, pp.151-159, 2005.
DOI : 10.1016/j.bbapap.2005.08.018

J. H. -no, Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries, Acta Tropica, vol.155, pp.113-123, 2016.
DOI : 10.1016/j.actatropica.2015.12.016

M. -ouellette, M. Olivier, S. Sato, and B. Papadopoulou, Le parasite Leishmania ?? l?????re de la post-g??nomique, m??decine/sciences, vol.19, issue.10, pp.900-909, 2003.
DOI : 10.1051/medsci/20031910900

M. -parsons, E. A. Worthey, P. N. Ward, and J. C. Mottram, Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi, BMC Genomics, vol.6, issue.127, 2005.

M. P. -patricelli, A. K. Szardenings, M. Liyanage, T. K. Nomanbhoy, M. Wu et al., Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates, Biochemistry, vol.46, issue.2, pp.350-358, 2007.
DOI : 10.1021/bi062142x

P. -pescher, T. Blisnick, P. Bastin, and G. F. Späth, Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cellular Microbiology, vol.48, issue.7, pp.978-991, 2011.
DOI : 10.1111/j.1462-5822.2011.01593.x

S. R. -piersma, M. O. Warmoes, M. De-wit, I. De-reus, J. C. Knol et al., Whole gel processing procedure for GeLC-MS/MS based proteomics, Proteome Science, vol.11, issue.1, 2013.
DOI : 10.1038/nbt.1511

P. Bibliographie-poullet, S. Carpentier, and E. Barillot, myProMS, a web server for management and validation of mass spectrometry-based proteomic data, PROTEOMICS, vol.5, issue.15, pp.2553-2556, 2007.
DOI : 10.1002/pmic.200600784

J. -ptacek, G. Devgan, G. Michaud, H. Zhu, X. Zhu et al., Global analysis of protein phosphorylation in yeast, Nature, vol.285, issue.7068, pp.679-684, 2005.
DOI : 10.1038/nature04187

N. -rachidi, J. F. Taly, E. Durieu, O. Leclercq, N. Aulner et al., Pharmacological Assessment Defines Leishmania donovani Casein Kinase 1 as a Drug Target and Reveals Important Functions in Parasite Viability and Intracellular Infection, Antimicrobial Agents and Chemotherapy, vol.58, issue.3, pp.1501-1515, 2014.
DOI : 10.1128/AAC.02022-13

R. -rajasekaran, C. , and Y. P. , Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs, Drug Discovery Today, vol.20, issue.8, pp.958-968, 2015.
DOI : 10.1016/j.drudis.2015.04.006

R. M. -reguera, E. Calvo-Álvarez, R. Álvarez-velilla, and R. Balaña-fouce, Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?, International Journal for Parasitology: Drugs and Drug Resistance, vol.4, issue.3, pp.355-357, 2014.
DOI : 10.1016/j.ijpddr.2014.05.001
URL : https://hal.archives-ouvertes.fr/hal-01195602

-. , M. B. Hilley, J. D. Dickens, N. J. Wilkes, J. Bates et al., Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania, Genome Res, vol.21, pp.2129-2142, 2011.

-. , M. E. Ilg, T. Nikolaev, A. V. Ferguson, M. A. Bates et al., Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG, Nature, vol.430, pp.463-467, 2004.

D. -rosenzweig, D. Smith, F. Opperdoes, S. Stern, R. W. Olafson et al., Retooling Leishmania metabolism: from sand fly gut to human macrophage, The FASEB Journal, vol.22, issue.2, pp.590-602, 2007.
DOI : 10.1096/fj.07-9254com

D. -rosenzweig, D. Smith, F. Opperdoes, S. Stern, R. W. Olafson et al., Retooling Leishmania metabolism: from sand fly gut to human macrophage, The FASEB Journal, vol.22, issue.2, pp.590-602, 2008.
DOI : 10.1096/fj.07-9254com

D. -sacks and S. Kamhawi, Molecular Aspects of Parasite-Vector and Vector-Host Interactions in Leishmaniasis, Annual Review of Microbiology, vol.55, issue.1, pp.453-483, 2001.
DOI : 10.1146/annurev.micro.55.1.453

A. Saxena, T. Lahav, N. Holland, G. Aggarwal, A. Anupama et al., Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation, Molecular and Biochemical Parasitology, vol.152, issue.1, pp.53-65, 2007.
DOI : 10.1016/j.molbiopara.2006.11.011

J. -seaman, A. J. Mercer, and E. Sondorp, The Epidemic of Visceral Leishmaniasis in Western Upper Nile, Southern Sudan: Course and Impact from 1984 to 1994, International Journal of Epidemiology, vol.25, issue.4, pp.862-871, 1984.
DOI : 10.1093/ije/25.4.862

J. M. -silverman, S. K. Chan, D. P. Robinson, D. M. Dwyer, D. Nandan et al., Proteomic analysis of the secretome of Leishmania donovani, Genome Biology, vol.9, issue.2, p.35, 2008.
DOI : 10.1186/gb-2008-9-2-r35

D. C. -swinney, Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines, Clinical Pharmacology & Therapeutics, vol.4, issue.4, pp.299-301, 2013.
DOI : 10.1021/jm040195b
URL : https://hal.archives-ouvertes.fr/hal-00658819

G. C. -terstappen, C. Schlüpen, R. Raggiaschi, and G. Gaviraghi, Target deconvolution strategies in drug discovery, Nature Reviews Drug Discovery, vol.278, issue.11, pp.891-903, 2007.
DOI : 10.1038/nrd2410

P. -tsigankov, P. F. Gherardini, M. Helmer-citterich, G. F. Spath, P. J. Myler et al., Regulation Dynamics of Leishmania Differentiation: Deconvoluting Signals and Identifying Phosphorylation Trends, Molecular & Cellular Proteomics, vol.13, issue.7, pp.1787-1799, 2014.
DOI : 10.1074/mcp.M114.037705

P. -tsigankov, P. F. Gherardini, M. Helmer-citterich, and D. Zilberstein, What has proteomics taught us about Leishmania development?, Parasitology, vol.58, issue.09, pp.1146-1157, 2012.
DOI : 10.1186/1471-2164-11-31

J. G. Bibliographie-villamor, F. Kaschani, T. Colby, J. Oeljeklaus, D. Zhao et al., Profiling Protein Kinases and Other ATP Binding Proteins in Arabidopsis Using Acyl-ATP Probes, Molecular & Cellular Proteomics, vol.12, issue.9, pp.2481-2496, 2013.
DOI : 10.1074/mcp.M112.026278

R. J. -wheeler, E. Gluenz, and K. Gull, The Limits on Trypanosomatid Morphological Diversity, PLoS ONE, vol.323, issue.47, p.79581, 2013.
DOI : 10.1371/journal.pone.0079581.s001

L. M. -wolfe, U. Veeraraghavan, S. Idicula-thomas, S. Schurer, K. Wennerberg et al., A Chemical Proteomics Approach to Profiling the ATP-binding Proteome of Mycobacterium tuberculosis, Molecular & Cellular Proteomics, vol.12, issue.6, pp.1644-1660, 2013.
DOI : 10.1074/mcp.M112.025635

M. W. -wooten, In-Gel Kinase Assay as a Method to Identify Kinase Substrates, Science Signaling, vol.2002, issue.153, pp.15-15, 2002.
DOI : 10.1126/stke.2002.153.pl15

W. L. -yau, T. Blisnick, J. F. Taly, M. Helmer-citterich, C. Schiene-fischer et al., Cyclosporin A Treatment of Leishmania donovani Reveals Stage-Specific Functions of Cyclophilins in Parasite Proliferation and Viability, PLoS Neglected Tropical Diseases, vol.361, issue.1, p.729, 2010.
DOI : 10.1371/journal.pntd.0000729.s002

J. -zhang, P. L. Yang, and N. S. Gray, Targeting cancer with small molecule kinase inhibitors, Nature Reviews Cancer, vol.62, issue.1, pp.28-39, 2009.
DOI : 10.1016/S0092-8674(03)00194-6

E. E. -zijlstra, A. M. Musa, E. A. Khalil, I. M. Hassan, and A. M. Hassan, Post-kala-azar dermal leishmaniasis, The Lancet Infectious Diseases, vol.3, issue.2, pp.87-98, 2003.
DOI : 10.1016/S1473-3099(03)00517-6